VERAVera Therapeutics, Inc. Class A Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 23288
Ticker: VERA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-05-14
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: VERA

Detail

Enriched 2026-08-14 20:47

Market cap: $2,161,179,416.65
Shares outstanding (class): 71,782,904
Shares outstanding (weighted): 72,063,335
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 361
Location: BRISBANE, CA
Homepage: https://www.veratx.com
Description: Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Market cap and share counts drift.

Funds holding this security

104 funds · 105 positions · $480.39M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$76.92M	1.03%	1,912,054 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$76.46M	0.00%	1,900,606 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$60.69M	0.08%	1,508,608 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$49.72M	0.46%	1,235,806 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$45.22M	0.35%	1,123,946 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$28.90M	0.04%	718,374 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$27.43M	0.33%	681,881 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$20.33M	0.17%	505,367 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$16.89M	0.21%	419,778 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$4.90M	0.12%	121,842 NS	FIGI
EQ/AB Small Cap Growth Portfolio EQ Advisors Trust	—	$4.85M	0.26%	120,485 NS	FIGI
VOYA MIDCAP OPPORTUNITIES PORTFOLIO Voya Variable Products Trust	—	$4.28M	0.50%	106,433 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$4.04M	0.08%	100,492 NS	FIGI
T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II	—	$3.65M	0.34%	90,626 NS	FIGI
Small Cap Core Portfolio Bernstein Fund Inc	—	$3.56M	0.50%	88,390 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERVERA
FIGI_COMPOSITEBBG00Q72WYG3
FIGI_SHARE_CLASSBBG00Q72WYH2
CIK0001831828
ISINUS92337R1014
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Vera Therapeutics is a biopharmaceutical company developing treatments for immune diseases, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.